GRI Bio, Inc.
Pharmaceutical company · La Jolla, California, United States · Nasdaq: GRI
GRI Bio, Inc. is a pharmaceutical company headquartered in La Jolla, California, United States. Its shares trade on Nasdaq under the ticker GRI. It has reported private securities offerings to the US SEC, most recently $762,236 sold in a notice filed in 2024.
GRI Bio at a glance
What does GRI Bio do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $762,236 sold (2024).
Frequently asked questions about GRI Bio
Where is GRI Bio headquartered?
GRI Bio, Inc. is headquartered in La Jolla, California, United States.
What does GRI Bio do?
GRI Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is GRI Bio a public company?
Yes. GRI Bio, Inc. trades on Nasdaq under the ticker GRI.
Similar companies
- CalciMedica, Inc.La Jolla, California, United States
- Ensysce Biosciences, Inc.La Jolla, California, United States
- Boundless Bio, Inc.La Jolla, California, United States
- Longboard Pharmaceuticals, Inc.La Jolla, California, United States
- Auspex Pharmaceuticals, Inc.La Jolla, California, United States
- Sophiris Bio Inc.La Jolla, California, United States
- Orexigen Therapeutics, Inc.La Jolla, California, United States
- Ambrx IncLa Jolla, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences